Latest News of LEGN
Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ...
By Yahoo! Finance |
1 week ago
Legend Biotech's CEO expects sequential growth in Q4 without specific guidance. FDA regulations impact CAR-T production, but Legend Biotech leads in revenue and slots among commercial CAR-T brands....
Legend Biotech Corporation (LEGN): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance |
2 months ago
A list of the top biotech hedge funds and stocks was compiled, focusing on Legend Biotech Corporation. Biotech investments are risky due to clinical trials and high costs....
Legend Biotech Corporation (LEGN) Stock Price, News, Quote & History
By Yahoo! Finance |
4 months ago
Legend Biotech Corporation is a biopharmaceutical company specializing in cell therapies for oncology. Their lead product, LCAR-B38M, targets multiple myeloma, with a portfolio of CAR-T candidates for...
-
Does Legend Biotech (LEGN) Have a Long Runway for Growth?
By Yahoo! Finance | 4 months agoTimesSquare Capital Management released its U.S. Focus Growth Strategy investor letter, reporting a 11.72% return in the first quarter. The strategy focuses on high-quality and low-valuation stocks. L...